Oral osteonecrosis associated with the use of zoledronic acid: first case of a patient with advanced pancreatic cancer and bone metastases

MeSH terms

• Adenocarcinoma / drug therapy
• Adenocarcinoma / pathology
• Bone Density Conservation Agents / adverse effects
• Bone Density Conservation Agents / therapeutic use
• Bone Neoplasms / drug therapy
• Bone Neoplasms / secondary
• Diphosphonates / adverse effects*
• Diphosphonates / therapeutic use
• Humans
• Imidazoles / adverse effects*
• Imidazoles / therapeutic use
• Jaw Diseases / chemically induced*
• Male
• Middle Aged
• Neoplasm Staging
• Osteonecrosis / chemically induced*
• Pancreatic Neoplasms / drug therapy
• Pancreatic Neoplasms / pathology
• Zoledronic Acid